What is the most common reason for unexpected delays in pharmaceutical product launches after FDA approval?

In the highly regulated medical industry, product launches face unique challenges that can significantly delay market entry. Understanding these obstacles is crucial for pharmaceutical product managers and healthcare professionals. This poll tests your knowledge about the most common reason for unexpected delays in new medication releases, revealing insights into the complex journey from development to market availability.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Manufacturing scale-up complications
Post-approval label negotiations with regulators
Supply chain disruptions for active ingredients
Last-minute changes to marketing strategy